MedTrace Logo

Thermoacoustic Method for Estimating Liver Fat Fraction

NCT07321925 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 49

Last updated 2026-01-07

No results posted yet for this study

Summary

The goal of this study is to use our Thermoacoustic Enhanced Ultrasound device to measure the fat levels in your liver and compare it to the the gold standard MRI PDFF measurements. Participants will have a scan with our device, then they will go have an abdominal MRI completed. The goal is to create a more accessible device to measure liver fat as it is an indicator for overall health and metabolic diseases.

Conditions

  • MASLD/MASH (Metabolic Dysfunction-Associated Steatotic Liver Disease / Metabolic Dysfunction-Associated Steatohepatitis)
  • Fatty Liver Disease, Nonalcoholic

Interventions

DEVICE

Thermoacoustic Enhanced Ultrasound

a novel Thermoacoustic Enhanced imaging device

Sponsors & Collaborators

  • Endra Lifesciences

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-08-15
Primary Completion
2025-10-30
Completion
2025-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07321925 on ClinicalTrials.gov